Dr. Reid Robison, MD, MBA (He/Him)

Dr. Reid Robison, MD, MBA (He/Him), Chief Clinical Officer
Psychiatry leader and co-founder of Cedar Psychiatry. Recognized for leading research and treatment of eating disorders (EDs), early adoption of ketamine in psychiatry, and social entrepreneurship. Previously coordinating investigator in a MAPS-sponsored study on MDMA for EDs and lead of a Janssen study on ketamine for treatment-resistant depression. Dr. Robison was previously Chief Medical Officer at Novamind.